QDEL logo

QDELQuidelortho Corp

$14.13
$0.04
(0.28%)
Today
Closed $14.13
$0.00
(0.00%)
After Hours
Updated: 04:58 PM EDT
EarningsJul 29
Mkt Cap$963.54M
Vol1.22M
58

Bullish Sentiment

How do you feel about QDEL?

News
all
press releases
Is the Options Market Predicting a Spike in QuidelOrtho Stock?
Investors need to pay close attention to QDEL stock based on the movements in the options market lately.
Zacks
News Placeholder
More News
News Placeholder
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue?
QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
QDEL's Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market share.
Zacks
News Placeholder
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies PR Newswire SAN DIEGO, June 2, 2026 SAN...
PR Newswire
News Placeholder
McIntyre Partnerships' Analysis on QuidelOrtho Corporation (QDEL)
McIntyre Partnerships' Analysis on QuidelOrtho Corporation (QDEL...
Yahoo! Finance: News
News Placeholder
When Blood Compatibility Becomes a Pregnancy Risk
When Blood Compatibility Becomes a Pregnancy Risk When Blood Compatibility Becomes a Pregnancy Risk PR Newswire SAN DIEGO, May 21, 2026 SAN DIEGO, May 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 58 of its Science...
PR Newswire
News Placeholder
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences PR Newswire SAN DIEGO, May 20, 2026 SAN DIEGO, May 20, 2026 /PRNewswire/ --QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global...
PR Newswire
News Placeholder
Citigroup Has Lowered Expectations for QuidelOrtho (NASDAQ:QDEL) Stock Price
Citigroup decreased their target price on shares of QuidelOrtho from $30.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday...
MarketBeat
News Placeholder
QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y
QuidelOrtho posts a wider Q1 loss as revenues fell 10.5% year over year, with weakness in respiratory testing pressuring margins and cash flow.
Zacks
<
1
2
...
>

Advertisement|Remove ads.